Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

WellCare makes CVS Health its pharmacy benefit manager

Health insurer WellCare Health Plans said it would change its pharmacy benefit manager to CVS Health Corp from UnitedHealth Corp’s Optum Rx, effective Jan. 1. About 3.8 million WellCare members enrolled under its Medicaid, Medicare and prescription drug plans will be able to access CVS’ pharmacy network, WellCare said on Thursday. Pharmacy benefit managers administer […]

Read More »

Endo International Kills Deals with VIVUS and Acerus

Endo International plc (ENDP), via its Auxilium Pharmaceuticals (AUXL) and Endo Ventures Limited subsidiaries, announced today that it has ended commercialization deals with VIVUS, Inc. (VVUS) and with Acerus Pharmaceuticals Corporation (TRLPF). On Jan. 29, 2015, Dublin-based Endo International plc completed the acquisition of Auxilium Pharmaceuticals in a deal worth $2.6 billion. Endo is a […]

Read More »

Eating Potatoes On A Regular Basis May Up Risk Of T2DM, Study

Greater potato consumption is associated with increased risk of type 2 diabetes (T2D), according to a study published online Dec. 17 in Diabetes Care. Isao Muraki, M.D., Ph.D., from Osaka Center for Cancer and Cardiovascular Disease Prevention in Japan, and colleagues assessed data from three cohorts to examine the correlation between potato consumption and T2D. […]

Read More »

Early-Life Exercise Alters Gut Microbes, Promotes Healthy Brain And Metabolism, University of Colorado Study

Early-Life Exercise Alters Gut Microbes, Promotes Healthy Brain And Metabolism The human gut harbors a teeming menagerie of over 100 trillion microorganisms, and researchers at the University of Colorado Boulder have discovered that exercising early in life can alter that microbial community for the better, promoting healthier brain and metabolic activity over the course of […]

Read More »

India’s Cadila gets FDA warning for violating standards at two plants

India’s Cadila Healthcare Ltd said it received a warning from U.S. health regulators for violating manufacturing standards at two production sites in India, sending its shares down 17 percent to its biggest single-day percentage fall. The letter from the U.S. Food and Drug Administration cites issues at Cadila’s plants in the western state of Gujarat: […]

Read More »

Researchers describe controversial study of surgeon training

(Reuters Health) – Whether surgical trainees should be able to work long shifts is a matter of fierce debate, and the methods of a controversial study aimed at answering that question were outlined Wednesday in a top surgical journal. The results won’t be available until February. In the meantime, critics of the study say it […]

Read More »

More U.S. women using unapproved menopause hormones

(Reuters Health) – A growing number of U.S. women are filling prescriptions for unregulated hormones to ease menopause symptoms such as hot flashes and night sweats, a recent study suggests. Researchers focused on what’s known as compounded hormone therapy – prescriptions that are custom-blended by pharmacists instead of factory-made by drug companies and approved for […]

Read More »

Boston Scientific Engineer to Be Sentenced Today for Trade Secret Theft

Aaron Khieu, a former engineer with Boston Scientific Corp. (BSX) is expected to be sentenced today for the theft of intellectual property and trade secrets. In April, Khieu pleaded guilty in federal court to one felony count of stealing a trade secret. A federal grand jury had indicted him in September 2014 of 14 counts […]

Read More »

Novartis AG Finalizes Suffern, NY Plant Closure, Lays Off Remaining 61 Workers

December 30, 2015By Mark Terry, Breaking News Staff   Switzerland-based Novartis (NVS) announced that it is continuing with its plans to sell more than 160 acres around its Suffern, NY facilities. Novartis has been making fairly regular job cuts as the company restructures. On Jan. 19, 2015 it announced it was closing a manufacturing […]

Read More »

Acerus Announces Termination of NATESTO Agreement with Endo

Acerus Announces Termination of NATESTO™ Agreement with Endo TORONTO–(BUSINESS WIRE)– Acerus Pharmaceuticals Corporation (ASP.TO) today announced that the agreement with Endo Ventures Bermuda Limited (an affiliate of Endo International plc) relating to the commercialization of NATESTO™ in the United States and Mexico will be terminated, effective June 30, 2016. Under the terms of the agreement […]

Read More »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

December 2018 Focus: Healthcare Agency Roundtable, Mobile Marketing, and more!


Ad Right Bottom